Table 2.
MEDICATION | CLASS | INDICATION | IMPACT ON 5a-REDUCED NEUROSTEROIDS | REFERENCE |
---|---|---|---|---|
ANTIDEPRESSANTS | ||||
AMITRIPTYLINE | Tricyclic | MDD Off-label: anxiety, insomnia, treatment-resistant depression | + | (Jaworska-Feil et al., 2000) |
DOXEPIN | Tricyclic | MDD, insomnia Off-label: anxiety | ? | |
IMIPRAMINE | Tricyclic | MDD Off-label: insomnia | no effect | (Haduch et al., 2011; Uzunov et al., 1996; Guidotti & Costa, 1998) |
TRAZODONE | Atypical | MDD Off-label: insomnia, anxiety | + | (Korade et al., 2017) |
MIRTAZAPINE | Atypical | MDD Off-label: panic disorder, GAD, PTSD | + | (Schüle et al., 2006) |
FLUOXETINE | SSRI | MDD, OCD, panic disorder, treatment-resistant depression, acute depression in Bipolar I disorder, PMDD. Off-label: social anxiety disorder and PTSD | + | (Griffin & Mellon, 1999; Guidotti & Costa, 1998; Pinna et al., 2003; Uzunova et al., 1998; Guidotti & Costa, 1998) |
PAROXETINE | SSRI | MDD, OCD, GAD, PTSD, social anxiety disorder, PMDD | + | (Griffin & Mellon, 1999; Alessandr o Guidotti & Costa, 1998) |
SERTRALINE | SSRI | MDD, panic disorder, OCD, PTSD, social anxiety disorder, PMDD Off-label: GAD | + | (Griffin & Mellon, 1999) |
CITALOPRAM | SSRI | MDD Off-label: PMDD, OCD, panic disorder, GAD, PTSD, social anxiety disorder | ? | |
ESCITALOPRAM | SSRI | MDD, GAD Off-label: panic disorder, OCD, PTSD, social anxiety disorder, PMDD | + | (Haduch et al., 2011) |
VENLAFAXINE | SNRI | MDD, GAD, social anxiety disorder Off-label: PMDD | + | (Haduch et al., 2011) |
DESVENLAFAXINE | SNRI | MDD | ? | |
DULOXETINE | SNRI | MDD, GAD | ? | |
BUPROPION | Atypical | MDD, Seasonal affective disorder | ? | |
PHENELZINE | “Irreversible” MAOI | MDD, treatment-resistant depression | ? | |
ISOCARBOXAZID | “Irreversible” MAOI | MDD | ? | |
TRANYLCYPROMINE | “Reversible” MAOI | MDD Off-label: treatment-resistant depression, social anxiety disorder, panic disorder, atypical depression | ? | |
SELEGILINE | “Reversible” MAOI | MDD | ? | |
BREXANOLONE | Neurosteroi d Analog | PPD | + | (Balan et al., 2023) |
KETAMINE | Dissociative Anesthetic | Treatment-resistant depression | + | (Korneyev et al., 1993; Li et al., 2016) |
ANXIOLYTICS | ||||
ALPRAZOLAM | Benzodiaza pine | GAD, panic disorder, anxiety associated with depression. Off-label: PMS, PMDD, insomnia, adjunct with acute mania, acute psychosis | ? | |
CHLORDIAZEP OXIDE | Benzodiaza pine | GAD | ? | |
CLONAZEPAM | Benzodiaza pine | Panic disorder Off-label: adjunct treatment of acute mania, acute psychosis, or insomnia | no effect | (Korneyev et al., 1993; Tokuda et al., 2010) |
DIAZEPAM | Benzodiaza pine | anxiety disorder Off-label: insomnia | + | (Wolf et al., 2015) |
LORAZEPAM | Benzodiaza pine | anxiety disorder Off-label: insomnia, panic disorder, adjunct with acute mania or acute psychosis | ? | |
HYDROXYZINE | Antihistamine | Anxiety | ? | |
MADAZOLAM | Benzodiaza pine | Anxiety | + | (Dhir & Rogawski, 2012; Tokuda et al., 2010) |
ETIFOXINE | Benzooxazine | Anxiety | + | (Luc Do Rego et al., 2015; Wolf et al., 2015) |
BUSPIRONE | Azapirone | GAD | ? | |
ANTIPSYCHOTICS | ||||
OLANZAPINE | Thio-Benzodiaze pine | Schizophrenia, Bipolar I Disorder, treatment-esistant depression | + | (Marx et al., 2003; Marx, Shampine, et al., 2006) |
QUETIAPINE | Dibenzo-Thiazepine Derivative | Schizophrenia, depressive episodes in Bipolar I disorder, adjunctive treatment in MDD | no effect | (Marx, Shampine, et al., 2006) |
RISPERIDONE | Benzisoxazole Derivative | Schizophrenia, acute mania/mixed episodes due to Bipolar I dDsorder, irritability associated with autism spectrum disorder | no effect | (Marx et al., 2003) |
ZIPRASIDONE | Benzo-Thiazolyl-Piperazine Derivative | Schizophrenia, acute mania/mixed episodes due to Bipolar I Disorder | no effect | (Marx, Shampine, et al., 2006) |
ARIPIPRAZOLE | Benzisoxazole Derivative | Schizophrenia, Bipolar I Disorder | no effect | (Marx, Shampine, et al., 2006) |
CLOZAPINE | Dibenzo-Diazepine | Schizophrenia, suicidality in Schizophrenia | + | (Barbacci a et al., 2001; Marx et al., 2003; Marx, Shampine, et al., 2006) |
THIOTHIXENE | Thioxanthene Derivative | Schizophrenia | ? | |
THIORIDAZINE | Piperidine Phenothiazine | Schizophrenia. Off-label: depression with psychotic features | + | (Haduch et al., 2011) |
CHLORPROMA ZINE | Dimethylamine Phenothiazine Derivative | Schizophrenia, psychoses, hyperexcitability, combative behavior in children Off-label: Bipolar I Disorder | ? | |
HALOPERIDOL | Butyrophen one | Schizophrenia, manic states, drug-induced psychoses, hyperexcitability, agitation | no effect | (Barbaccia et al., 2001; Marx et al., 2003) |
PALIPERIDONE | Benzisoxazole Derivative | schizophrenia, schizoaffective disorder | ? | |
ASENAPINE | Dibenzo-Oxepino Pyrrroles | schizophrenia, manic/mixed episodes associated with bipolar I disorder | + | (Danek et al., 2021) |
LURASIDONE | Benzisoxaz ole Derivative | schizophrenia, depressive episodes in Bipolar I disorder | + | (Danek & Daniel, 2022) |
ILOPERIDONE | Benzisoxaz ole Derivative | schizophrenia | + | (Danek & Daniel, 2021) |
CARIPRAZINE | Atypical | schizophrenia, acute mania/mixed episodes due to bipolar I disorder | ? | |
BREXPIPRAZO LE | Serotonin-Dopamine Activity Modulators (SDAM) | schizophrenia, adjunct treatment of MDD | ? | |
MOOD STABILIZERS | ||||
LITHIUM | Antimanic | Bipolar I Disorder | + | (Marx et al., 2008; Maayan et al., 2004) |
CARBAMAZEPI NE | Anticonvuls ant | Bipolar I Disorder | + | (Eagle et al., 2020; Jaworska-Feil et al., 2000; Yoshizaw a et al., 2020) |
DIVALPROEX | Anticonvuls ant | Bipolar Disorder | ? | |
LAMOTRIGINE | Anticonvuls ant | Bipolar Disorder | ? |
indicates evidence of an interaction with the specified drug and neurosteroid synthesis,
indicates no known evidence of an interaction. Abbreviations: Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Post Traumatic Stress Disorder (PTSD), Obsessive Convulsive Disorder (OCD), Premenstrual Dysphoric Disorder (PMDD), Postpartum Depression (PPD), Premenstrual Syndrome (PMS).